Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
2023 | Nabriva Therapeutics plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 | CI |
2023 | Nabriva Therapeutics plc(OTCPK:NBRV.F) dropped from NASDAQ Composite Index | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
-.--% | 3 | |
+16.79% | 12TCr | |
+13.17% | 11TCr | |
-5.72% | 2.48TCr | |
+1.69% | 2.25TCr | |
-10.09% | 1.83TCr | |
-40.52% | 1.63TCr | |
-13.93% | 1.53TCr | |
+1.09% | 1.41TCr | |
+24.11% | 1.17TCr |
- Stock Market
- Equities
- NBRVF Stock
- News Nabriva Therapeutics plc
- Transcript : Nabriva Therapeutics plc Presents at Bank of America Merrill Lynch 2019 Healthcare Conference, May-15-2019 04